Published February 25, 2026
| Version v1
Other
Open
Can tirzepatide lower the incidence of cardiovascular events in patients without diabetes?
Description
Tirzepatide shows potential in reducing cardiovascular events in non-diabetic obese individuals, but more targeted studies are needed for precise confirmation.